NTLA vs ATEN Comparison

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

A10 Networks Inc is a provider of secure application solutions and services that enables a new generation of intelligently connected companies, the ability to continuously improve cyber protection and digital responsiveness across dynamic Information Technology and network infrastructures. Its portfolio consists of six secure application solutions; Thunder Application Delivery Controller, Lightning Application Delivery Controller, Thunder Carrier Grade Networking, Thunder Threat Protection System, Thunder SSL Insight and Thunder Convergent Firewall, and two intelligent management and automation tools; Harmony Controller and aGalaxy TPS. Key revenue is generated from the Americas, with the rest coming from Europe, the Middle East and Africa, plus the Asia Pacific region.